China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

China flag China · Delayed Price · Currency is CNY
17.96
+0.08 (0.45%)
Apr 29, 2026, 3:00 PM CST
-3.80%
Market Cap 18.47B
Revenue (ttm) 10.73B
Net Income (ttm) 1.63B
Shares Out 1.03B
EPS (ttm) 1.57
PE Ratio 11.40
Forward PE 10.55
Dividend 0.48 (2.69%)
Ex-Dividend Date n/a
Volume 6,405,392
Average Volume 9,503,988
Open 17.88
Previous Close 17.88
Day's Range 17.78 - 17.98
52-Week Range 17.69 - 22.14
Beta 0.05
RSI 43.15
Earnings Date Apr 25, 2026

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiar... [Read more]

Sector Healthcare
Founded 1939
Employees 13,184
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600062
Full Company Profile

Financial Performance

In 2025, SHA:600062's revenue was 11.00 billion, a decrease of -1.88% compared to the previous year's 11.21 billion. Earnings were 1.65 billion, an increase of 1.18%.

Financial Statements

News

There is no news available yet.